European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across RegionsMaría G. Crespo‐Leiro, Alexandre Mebazaa, Stefan D. Anker et al.|European Journal of Heart Failure|2016Cited by 781
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)Ferenc Folláth, Alexandre Mebazaa, Mehmet Birhan Yılmaz et al.|Intensive Care Medicine|2011Cited by 293
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methodsAlexandre Mebazaa, Ferenc Folláth, John Parissis et al.|Intensive Care Medicine|2010Cited by 228
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Cardiac failure review|2020Cited by 67